Literature DB >> 16150218

Acrokeratosis verruciformis of Hopf (Hopf disease): case report and review of the literature.

E Rallis1, A Economidi, P Papadakis, C Verros.   

Abstract

Acrokeratosis verruciformis of Hopf is an autosomal dominant genodermatosis usually presenting with multiple planar wart-like lesions, typically observed on the dorsum of the hands and feet. The disease is very rare and the pathogenesis remains unknown. Considerable controversy surrounds the nature and relationship of acrokeratosis and Darier disease and whether they are manifestations of one genetic abnormality. We describe the case of a 19-year-old man seen in our clinic with skin-coloured, flat, warty papules localized to the dorsum of the hands and feet. Both clinical and histological findings were compatible with acrokeratosis verruciformis. We also review the disease, particularly its relation with Darier disease and therapeutical options.

Entities:  

Mesh:

Year:  2005        PMID: 16150218

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  5 in total

1.  Nonfamilial acrokeratosis verruciformis of Hopf.

Authors:  Nidhi Patel; Nilofar Diwan; Pragya A Nair
Journal:  Indian Dermatol Online J       Date:  2015 Mar-Apr

2.  Acrokeratosis verruciformis of Hopf in family.

Authors:  Sanjay N Agrawal; Subodhkumar D Jane; Anuprita A Rawal
Journal:  Indian Dermatol Online J       Date:  2014-11

3.  Acrokeratosis Verruciformis of Hopf Clinically Mimicking Epidermodysplasia Verruciformis.

Authors:  Nilofar G Diwan; Nidhi B Jivani; Pragya Ashok Nair
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

4.  Polydactylous Transverse Erythronychia: Report of a Patient with Multiple Horizontal Red Bands Affecting the Fingernails.

Authors:  Carina Chang; Bryce D Beutler; Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2017-03-04

5.  Acrokeratosis verruciformis of hopf along lines of blaschko.

Authors:  Pragya A Nair
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.